Cytex’s technology, as published in the latest Proceedings of the National Academy of Sciences, is making a splash worldwide. Cytex’s scientists and cartilage resurfacing technology was featured in U.S. News and World Report Health News, The Huffington Post, Health, Yahoo News, and dozens of other news outlets in response to the recently published study in […]
Cytex’s VP of Research and Development, Dr. Brad Estes and Dr. Farsh Guilak, Professor of Orthopaedic Surgery at Washington University and Cytex’s President, co-led a team of researchers in a study published July 18, 2016 in the prestigious journal PNAS. Results from this study highlighted Cytex’s tissue engineered implants’ cartilage-like properties, ability to maintain complex […]
The ORS hosts the premier orthopaedic research conference for basic science and clinical researchers in the United States. Dr. Moutos presented findings from cutting-edge research in a talk entitled “Anatomically Shaped Tissue-Engineered Cartilage with Tunable and Inducible Anti-Cytokine Delivery for Biological Joint Resurfacing.”
Cytex is thrilled to add the expertise of Dr. Vincent P. Willard to our talented team. Dr. Willard brings over 14 years of research experience in molecular and stem cell biology, orthopaedic tissue engineering, and gene therapy to Cytex. He will serve as the Director of Regenerative Therapies.
Cytex is grateful for the support of the State of North Carolina. Cytex has been awarded a matching grant to compliment the work being achieved through its recently awarded federal SBIR Grant entitled Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model.
Cytex is grateful to the National Institutes of Health for a STTR award to begin development of a unicondylar cartilage resurfacing implant based on Cytex’s core 3-D weave technology.
Cytex is grateful to the National Institutes of Health for a phase II award to continue development of a biosynthetic implant for unicondylar cartilage resurfacing in the knee.
Dr. Sarah Compton has joined the staff at Cytex, bringing with her broad expertise in cell culture platforms with a specialization in the development and validation of cell based products for therapeutic applications. Sarah has a combined 10 years experience in research and development positions in both industry and academic settings, including the role of Director of Research […]
The USPTO issued patent number 8,691,542 on April 8, 2014. This patent covers the application of a tissue engineering approach using textiles for the resurfacing of the entire joint (or large portions thereof).
Cytex Therapeutics has been awarded a phase one grant from the NIH to study disease modifying compounds for the treatment of advanced osteoarthritis with researchers at Duke University.